| | |  | | | | Record from Web of Science® | | | | | | |
| Cutting the cost of drug development? |
|
|
| Author(s): Rawlins MD |
| Source: NATURE REVIEWS DRUG DISCOVERY Volume: 3 Issue: 4 Pages: 360-364A Published: APR 2004 |
| Times Cited: 35 References: 20 |
| Abstract: The cost of drug development has risen markedly in the past 30 years, with studies now reporting values exceeding US $800 million. As these spiralling costs threaten to make the development of new drugs increasingly unaffordable for both developing companies and consumers, it is clear that efforts should be made to address this problem. All aspects of the drug discovery and development process should be examined for potential cost savings, but I focus here in particular on the current regulatory requirements. |
| Document Type: Article |
| Language: English |
| Reprint Address: Rawlins, MD (reprint author), Univ Newcastle Upon Tyne, Sch Med, Wolfson Unit Clin Pharmacol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear England |
Addresses:
1. Univ Newcastle Upon Tyne, Sch Med, Wolfson Unit Clin Pharmacol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear England |
| Publisher: NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND |
| Subject Category: Biotechnology & Applied Microbiology; Pharmacology & Pharmacy |
| IDS Number: 808RX |
| ISSN: 1474-1776 |
| DOI: 10.1038/nrd1347 |
|
| | | | | | | | | Record from Web of Science® | | | | | | | | | |